Urinary arsenic profiles and the risks of cancer mortality: a population-based 20-year follow-up study in arseniasis-endemic areas in Taiwan
- PMID: 23276485
- DOI: 10.1016/j.envres.2012.11.007
Urinary arsenic profiles and the risks of cancer mortality: a population-based 20-year follow-up study in arseniasis-endemic areas in Taiwan
Abstract
Few studies investigated the association between chronic arsenic exposure and the mortality of cancers by estimating individual urinary arsenic methylation profiles. Therefore, we compared with the general population in Taiwan to calculate the standardized mortality ratio (SMR) in arseniasis-endemic area of Taiwan from 1996 to 2010 and evaluated the dose-response relationships between environmental arsenic exposure indices or urinary arsenic profiles and the mortality of cause-specific cancer. A cohort of 1563 residents was conducted and collected their urine sample and information regarding arsenic exposure from a questionnaire. All-cause death was identified using the National Death Registry of Taiwan. Urinary arsenic profiles were measured using high performance liquid chromatography-hydride generator-atomic absorption spectrometry. We used Cox proportional hazard models to evaluate the mortality risks. In results, 193 all-site cancer deaths, and 29, 71, 43 deaths respectively for liver, lung and bladder cancers were ascertained. The SMRs were significantly high in arseniasis-endemic areas for liver, lung, and bladder cancers. People with high urinary InAs% or low DMA% or low secondary methylation index (SMI) were the most likely to suffer bladder cancer after adjusting other risk factors. Even stopping exposure to arsenic from the artesian well water, the mortality rates of the residents were higher than general population. Finally, urinary InAs%, DMA% and SMI could be the potential biomarkers to predict the mortality risk of bladder cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
-
Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.Cancer Causes Control. 2008 Oct;19(8):829-39. doi: 10.1007/s10552-008-9146-5. Epub 2008 Mar 20. Cancer Causes Control. 2008. PMID: 18351295
-
Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan.Toxicol Appl Pharmacol. 2007 Jan 15;218(2):135-42. doi: 10.1016/j.taap.2006.10.022. Epub 2006 Oct 28. Toxicol Appl Pharmacol. 2007. PMID: 17173945
-
Hypertension incidence after tap-water implementation: a 13-year follow-up study in the arseniasis-endemic area of southwestern Taiwan.Sci Total Environ. 2011 Oct 1;409(21):4528-35. doi: 10.1016/j.scitotenv.2011.07.058. Epub 2011 Aug 26. Sci Total Environ. 2011. PMID: 21872294
-
Does arsenic exposure increase the risk for liver cancer?J Toxicol Environ Health A. 2004 Oct 8;67(19):1491-500. doi: 10.1080/15287390490486806. J Toxicol Environ Health A. 2004. PMID: 15371225 Review.
-
Arsenic and diabetes: current perspectives.Kaohsiung J Med Sci. 2011 Sep;27(9):402-10. doi: 10.1016/j.kjms.2011.05.008. Epub 2011 Jul 6. Kaohsiung J Med Sci. 2011. PMID: 21914528 Review.
Cited by
-
Resveratrol Alleviates Arsenic Exposure-Induced Liver Fibrosis in Rats by Inhibiting Hepatocyte Senescence.Biol Trace Elem Res. 2024 Jun 3. doi: 10.1007/s12011-024-04255-9. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38831176
-
Benchmark dose modeling for epidemiological dose-response assessment using prospective cohort studies.Risk Anal. 2024 Apr;44(4):743-756. doi: 10.1111/risa.14196. Epub 2023 Jul 27. Risk Anal. 2024. PMID: 37496455
-
Arsenic and cancer: Evidence and mechanisms.Adv Pharmacol. 2023;96:151-202. doi: 10.1016/bs.apha.2022.08.001. Epub 2022 Sep 27. Adv Pharmacol. 2023. PMID: 36858772 Free PMC article.
-
Joint effects of genomic markers and urinary methylation capacity associated with inorganic arsenic metabolism on the occurrence of cancers among residents in arseniasis-endemic areas: A cohort subset with average fifteen-year follow-up.Biomed J. 2021 Dec;44(6 Suppl 2):S218-S225. doi: 10.1016/j.bj.2020.10.005. Epub 2020 Oct 13. Biomed J. 2021. PMID: 35297370 Free PMC article.
-
Heavy Metals and Probabilistic Risk Assessment via Pheretima (a Traditional Chinese Medicine) Consumption in China.Front Pharmacol. 2022 Jan 5;12:803592. doi: 10.3389/fphar.2021.803592. eCollection 2021. Front Pharmacol. 2022. PMID: 35069214 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical